This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Judge splits liability portion of Provigil case into two phases

( June 8, 2017, 21:09 GMT | Official Statement) -- MLex Summary: US District Judge Mitchell Goldberg has split the liability portion of a trial in a case accusing Cephalon and four generic drug companies of illegally delaying generic versions of the sleep disorder drug Provigil. Goldberg decided to separate the trial into violation and causation, and to only inform the jury during the causation portion that the relevant patent was invalidated, saying that the ruling is irrelevant to the rule of reason analysis but relevant to an antitrust causation showing. See document below. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections